top of page
AI pixabay huge.jpg

Leveraging the Full Value of Digital Biomarkers Requires Payer Buy-In

Getting payer buy-in, thus acceptance and recognition, will be critical toward realizing the vast potential of this exciting new technology. Here's where I see the future of digital biomarkers heading, as well as the steps that can help ensure payers are on board.



Comments


bottom of page